Local application of bFGF and sucralfate during continuous tissue expansion.
- Author:
Ya-lan HU
1
;
Shu-zhong GUO
;
Kai-hua LU
;
Yan HAN
;
Yong-hong LEI
;
Bao-qiang SONG
;
Yong PAN
Author Information
- Publication Type:Journal Article
- MeSH: Capillaries; anatomy & histology; Cell Proliferation; Collagen; analysis; Dermis; blood supply; pathology; Epidermis; cytology; Fibroblast Growth Factors; pharmacology; Fibroblasts; cytology; Humans; Length of Stay; Nose Deformities, Acquired; surgery; Sucralfate; pharmacology; Surgical Flaps; blood supply; Time Factors; Tissue Expansion; instrumentation; methods; Tissue Expansion Devices; Treatment Outcome
- From: Chinese Journal of Plastic Surgery 2003;19(1):39-41
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the effect of local application of bFGF and sucralfate during continuous tissue expansion (CTE).
METHODSCTE combined with local administration of bFGF and sucralfate was used in twelve patients with scar and nasal tip defects. Twenty three expanders were placed in the subcutaneous pockets through intralesion short incisions. Continuous expansion began at 1-3 days after expander implantation. The histomorphological changes and epidermal cell proliferation were observed. The clinical results were investigated.
RESULTSThe average inflation time was 8.9 days. The average interval of the two operations was 13.5 days. The average hospitalization was 28.4 days. The average immediate stretch-back rate of the expanded skin was 25.7%. The clinical results were satisfactory without any complications. Histological examinations showed that the epidermal, granular and spinous layer became thicker. The basal cells increased significantly. The dermis thinned slightly and the collagen fibers became thicker. The elastic fiber regenerated significantly. Fibroblast and capillary density increased obviously. The immunohistochemistry analysis showed that the proliferation of epidemic basal cells was significant postoperatively.
CONCLUSIONLocal application of exogenous bFGF and sucralfate during CTE was feasible in patients. It could accelerate tissue expansion and improve the quality of expanded skin flap.